Press Releases April 21, 2026 07:18 AM

Northrop Grumman Releases First Quarter 2026 Financial Results

Northrop Grumman announces Q1 2026 earnings and hosts webcast for investor update

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
NOC

Northrop Grumman Corporation released its financial results for the first quarter of 2026 and scheduled a live webcast of its earnings conference call to provide detailed insights to investors. The company continues to focus on delivering advanced aerospace and defense technology solutions.

Northrop Grumman Releases First Quarter 2026 Financial Results
NOC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Northrop Grumman reported Q1 2026 financial results as per regulatory filings.
  • The company scheduled a webcast for its earnings call to engage with investors.
  • Northrop Grumman emphasizes its leadership in global aerospace and defense technology sectors.

FALLS CHURCH, Va., April 21, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) has released its first quarter 2026 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available on the company's investor relations website at http://investor.northropgrumman.com.

Earnings Call Webcast

As previously announced, Northrop Grumman will webcast its earnings conference call at 9:30 a.m. Eastern time today. A live audio broadcast of the conference call will be available on http://investor.northropgrumman.com.

About Northrop Grumman

Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers’ toughest problems, our employees define possible every day.

Media Contact

News Bureau
newsbureau@ngc.com

Todd Ernst
todd.ernst@ngc.com


Risks

  • Potential market and economic conditions could impact future contract awards and revenues.
  • Dependence on government defense budgets and policies may affect business performance.
  • Technological innovations by competitors could pose challenges to sustaining market leadership.

More from Press Releases

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026 Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference Sep 4, 2026